Surgical Innovations Group expects flat annual revenues

Surgical Innovations Group's shares tumbled Tuesday after the company said 2012 revenues were hit by manufacturing capacity constraints and delays in regulatory approvals in the final quarter.

Surgical Innovations Group's shares tumbled Tuesday after the company said 2012 revenues were hit by manufacturing capacity constraints and delays in regulatory approvals in the final quarter.

Shares fell almost 15% on the morning of the announcement as the group said it expected total revenue last year to come to £7.6m, unchanged from 2011.

The designer and manufacturer of solutions for surgery said manufacturing capacity constraints its UK facility in Leeds and a delay in US regulatory approval impacted revenues towards the end of the financial year. As a result, revenues of £1.0m were not seen until January.

Nevertheless, trading improved 85% to £5.6m during the last half of the year, driven by an increase in product orders.

The company's SI Brand business represented 68% of overall revenues, compared to 62% in 2011.

Gross margins were anticipated to have improved by three basis points to 50.3%, up from 47.3% the year earlier.

Adjusted earnings before interest, tax, depreciation, and amortisation (EBITDA) for the period was projected to reach £2.85m, up from £2.8m.

The firm ended the year with short term borrowings of £1.4m against bank facilities provided by HSBC of £2.0m.

Graham Bowland, Chief Executive Officer, said: "I am pleased with the strong sales performance that we've achieved in the second half of the year.

"There is no doubt that the manufacturing capacity constraints we experienced in the final quarter of 2012 justify the need for our proposed new facility part funded by the award of the £5.0m regional growth fund."

RD

Recommended

Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Three fast-growing, undervalued UK mid-cap stocks to buy now
Share tips

Three fast-growing, undervalued UK mid-cap stocks to buy now

Professional investor Katen Patel of the JPMorgan Mid Cap Investment Trust picks three fast-growing UK mid-cap stocks to buy now.
18 May 2022
Should you buy Vodafone shares, or steer clear?
Share tips

Should you buy Vodafone shares, or steer clear?

Vodafone grew revenue by 4% and profit by 11% last year, and offers investors a 6.4% dividend yield. So should you buy Vodafone shares? Rupert Hargrea…
17 May 2022

Most Popular

Get set for another debt binge as real interest rates fall
UK Economy

Get set for another debt binge as real interest rates fall

Despite the fuss about rising interest rates, they’re falling in real terms. That will blow up a wild bubble, says Matthew Lynn.
15 May 2022
Is the oil market heading for a supply glut?
Oil

Is the oil market heading for a supply glut?

Many people assume that the high oil price is here to stay – and could well go higher. But we’ve been here before, says Max King. History suggests tha…
16 May 2022
Value is starting to emerge in the markets
Investment strategy

Value is starting to emerge in the markets

If you are looking for long-term value in the markets, some is beginning to emerge, says Merryn Somerset Webb. Indeed, you may soon be able to buy tra…
16 May 2022